Dr Reddy's Laboratories
(NYSE:RDY)
$69.17
-0.29[-0.42%]
At close: May 10
$69.17
0[0.00%]
After Hours: 4:00PM EDT
Q4 2024 Earnings were released on Tue May 7th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Dr Reddy's Laboratories Stock (NYSE:RDY), Quotes and News Summary

Dr Reddy's Laboratories Stock (NYSE: RDY) stock price, news, charts, stock research, profile.

Open$69.610
Close$69.170
Volume / Avg.568.352K / 188.098K
Day Range69.130 - 70.030
52 Wk Range53.120 - 77.720
Market Cap$11.519B
P/E Ratio17.328
Dividend Yield0.700%
ExchangeNYSE
RSI
34
Short Interest
0.45%
Days to Cover4.12

Recent News

Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
Indian pharmaceutical giants, including Sun Pharma and Cipla, seize the opportunity to develop affordable versions of Novo Nordisk's Wegovy weight-loss treatment. With patents set to expire by 2026-2032, these generics aim to address India's rising obesity and diabetes concerns, anticipating substantial market growth in the next decade.
Vandana Singh
Top 5 Health Care Stocks That May Fall Off A Cliff
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Lisa Levin
Why Are Journey Medical Shares Trading Lower Today?
Journey Medical Corporation (NASDAQ: DERM) shares are trading lower after the company announced topline results from the two Phase 3 trials, evaluating Minocycline Hydrochloride Modified Release Capsules (DFD-29) for adult patients with moderate-to-severe 
Vandana Singh
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RDY
NVO

FAQ

Q

How do I buy Dr Reddy's Laboratories (RDY) stock?

A

You can purchase shares of Dr Reddy's Laboratories (NYSE: RDY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Dr Reddy's Laboratories's (RDY) competitors?

A

Other companies in Dr Reddy's Laboratories’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Dr Reddy's Laboratories (RDY) stock?

A

The latest price target for Dr Reddy's Laboratories (NYSE: RDY) was reported by Barclays on Wednesday, May 8, 2024. The analyst firm set a price target for 81.00 expecting RDY to rise to within 12 months (a possible 17.10% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Dr Reddy's Laboratories (RDY)?

A

The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $69.17 last updated May 10, 2024 at 7:00 PM EDT.

Q

Does Dr Reddy's Laboratories (RDY) pay a dividend?

A

A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on August 12, 2022 to stockholders of record on July 8, 2022.

Q

When is Dr Reddy's Laboratories (NYSE:RDY) reporting earnings?

A

Dr Reddy's Laboratories’s Q1 earnings are confirmed for Wednesday, July 24, 2024.

Q

Is Dr Reddy's Laboratories (RDY) going to split?

A

There is no upcoming split for Dr Reddy's Laboratories.

Q

What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

A

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch